The results showed a significant reduction in Ki-67 expression in the trametinib-treated MED12 KO tumors compared to those treated with ceritinib, indicating that trametinib effectively inhibits tumor cell proliferation (Fig. 4F). The gene discussed is MKI67; the disease is neoplasm.